Indonesian Honeybee Venom Shows Promise in Breast Cancer Treatment Research

The venom of Indonesian honeybees holds potential new possibilities for breast cancer treatment. Melittin, the main component of this venom, has demonstrated an ability to inhibit the proliferation of aggressive breast cancer cells in laboratory studies. A 2020 study conducted in Australia confirmed that melittin can destroy the cell membranes of breast cancer cells and significantly reduce the chemical signals necessary for their growth within approximately 20 minutes. This is believed to be a mechanism that halts the division and proliferation of cancer cells by disrupting intracellular signaling pathways. However, this discovery is still in its early stages, and numerous challenges remain for its practical application. Melittin is effective only at specific dosages; excessive administration could also damage healthy cells. Furthermore, its rapid degradation in the bloodstream raises concerns that its effects may be lost before reaching tumors. The difficulty in controlling direct use of bee venom and the risk of severe allergic reactions are also noted concerns. To overcome these challenges, researchers are looking to nanotechnology. Methods are being explored to encapsulate melittin within tiny particles such as liposomes, micelles, or polymer nanoparticles, allowing them to be delivered directly to cancer cells. This approach is expected to enhance melittin's efficacy and reduce side effects. Indonesia boasts rich biodiversity, with a history of utilizing numerous medicinal plants and animal-derived compounds in traditional medicine. This research on honeybee venom suggests that Indonesia's natural resources could make new contributions in the field of advanced medical treatment. Future research progress is anticipated to bring new hope to cancer therapy. Source: Mongabay Indonesia